BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell differentiation
,
Ischemia
,
Retina
,
Anticancer prodrugs
,
Quercetin
,
rs6983267
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ABL)1
Summary
General Info
Curated Studies
Most Correlated Studies
Bone marrow gene expression of pediatric acute lymphoblastic leukemia
Explore Curated Studies Results
Literature
Most Relevant Literature
The Abl-1 Kinase is Dispensable for NK Cell Inhibitory Signalling and is not Involved in Murine NK C…
LC-ESI-MS method for the monitoring of Abl 1 tyrosine kinase.
Exploration of N-(2-aminoethyl)piperidine-4-carboxamide as a potential scaffold for development of V…
Isoflurane impairs oogenesis through germ cell apoptosis in C. elegans.
Validation of Endogenous Control Genes by Real-Time Quantitative Reverse Transcriptase Polymerase Ch…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm)
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) C…
Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembro…
Are the Continuous Glucose Monitoring Systems Able to Improve Long Term Glycaemic Control in Type 1 …
A Clinical Trial of Stereotactic Ablative Radiotherapy for Metastatic Lymphadenopathy
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ